Voyager Therapeutics
This company is dedicated to breaking through barriers in gene therapy and neurology. Learn more
Launch date
Employees
Market cap
€310m
Enterprise valuation
€15m (Public information from Sep 2024)
Share price
$6.32 VYGR
Cambridge Massachusetts (HQ)
Authorizing premium user...